Bleeding Disorder Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
出血性疾病是指通过阻止血友病患者或患有其他出血性疾病的人形成血栓来破坏血液凝固过程的病症。这些出血性疾病大多数是遗传性的,但也有一些是由于肝脏疾病、某些药物的副作用、红细胞计数低、维生素 K 缺乏等引起的。出血性疾病治疗市场的关键驱动因素是慢性疾病、肝脏疾病、贫血和其他血液疾病的患病率不断上升。
市场范围
《至2028年全球出血性疾病治疗市场分析》是对医疗保健行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在概述出血性疾病治疗市场,并按疾病类型、药物类别和分销渠道进行详细的市场细分。该报告提供了主要出血性疾病治疗市场参与者的市场状况的关键统计数据,并提供了市场的主要趋势和机会。市场细分
- • 根据疾病类型,市场分为甲型血友病、乙型血友病、冯维勒布兰德病等。• 根据药物类别,市场分为血浆源性凝血因子浓缩物、重组凝血因子浓缩物、去氨加压素、抗纤维蛋白溶解剂、纤维蛋白密封剂等。• 根据分销渠道,市场分为医院药房、零售药房和在线药房。
市场动态
驱动因素:< br />
- • 出血性疾病的患病率不断上升,人们对出血性疾病治疗的认识也不断提高。• 存在其他慢性疾病以及诊断和治疗出血性疾病的强大网络。• 增加医疗支出和广泛的研发工作来开发治疗出血性疾病的新疗法。
限制:
- • 然而,出血性疾病治疗药物的高成本和报销不足预计将限制预测期内的市场增长。
Bleeding Disorder Treatment Market: Strategic Insights
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals, Inc
- Amgen, Inc.
- Takeda Pharmaceuticals U.S.A., Inc
- Bayer AG
- Grifols, S.A.
- Octapharma AG
- Novo Nordisk A/S
- Pfizer, Inc.
- Sanofi
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美
- 欧洲
- 亚太地区
- 南美洲和中美洲
- 中东和非洲
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- 血友病 A
- 血友病 B
- 血管性血友病
- 其他
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 血浆源性凝血因子浓缩物
- 重组凝血因子浓缩物
- 去氨加压素
- 抗纤维蛋白溶解剂
- 纤维蛋白封闭剂等
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- 医院药房
- 零售药房
- 网上药房
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 北美
- 欧洲
- 亚太地区
- 南美洲和中美洲
该报告提供了行业的详细概述,包括定性和定量信息。它提供了基于各个细分市场的全球市场的概述和预测。它还提供了 2019 年至 2028 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美洲。每个地区的出血性疾病治疗市场随后按各自的国家和细分市场进行细分。报告涵盖了全球18个国家以及该地区当前的趋势和机遇的分析和预测。
报告从需求和供给两个方面分析了影响市场的因素,并进一步评估了影响市场的市场动态。预测期,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:在评估影响北美、欧洲、亚太地区、中东和非洲和南美洲这些地区出血性疾病治疗市场的政治、经济、社会和技术因素后。
COVID-19 对出血的影响紊乱治疗市场
COVID-19 于 2019 年 12 月首次在中国武汉爆发,此后在全球范围内快速传播。从确诊病例和死亡人数来看,美国、印度、巴西、俄罗斯、法国、英国、土耳其、意大利和西班牙是受影响最严重的国家。由于封锁、旅行禁令和企业关闭,COVID-19 一直在影响各国的经济和行业。各种工厂和工厂的关闭影响了全球供应链,并对全球市场产品的制造、交货时间表和销售产生了负面影响。很少有公司已经宣布可能推迟产品交付以及未来产品销量的下滑。根据当前市场形势,报告进一步评估了COVID-19大流行对整体市场当前和未来的影响,给出了更可靠、更真实的预测。除此之外,欧洲、亚洲国家实施的全球旅行禁令——太平洋和北美正在影响业务合作和伙伴关系机会。
市场参与者
该报告涵盖了出血性疾病治疗市场的主要发展,包括有机和无机增长策略。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上见证的无机增长战略活动包括收购、合作伙伴关系和合作伙伴关系。合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对出血性疾病治疗的需求不断增长,出血性疾病治疗市场的市场支付者预计未来将获得利润丰厚的增长机会。
该报告还包括出血性疾病治疗市场中主要公司的概况及其 SWOT 分析和市场策略。此外,该报告重点关注行业领先企业,提供公司简介、所提供的组件和服务、过去三年的财务信息、过去五年的主要发展等信息。
- • Alnylam 制药公司• 安进公司• 武田药品美国公司• 拜耳股份公司• 格里福尔斯,SA• Octapharma AG• 诺和诺德公司• 辉瑞公司• 赛诺菲• CSL
The Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。
Bleeding Disorder Treatment Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ XX million |
Market Size by | US$ XX Million |
Global CAGR | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By 疾病类型
|
Regions and Countries Covered |
北美
|
Market leaders and key company profiles |
|
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
- Alnylam Pharmaceuticals, Inc
- Amgen, Inc.
- Takeda Pharmaceuticals U.S.A., Inc
- Bayer AG
- Grifols, S.A.
- Octapharma AG
- Novo Nordisk A/S
- Pfizer, Inc.
- Sanofi
- CSL
- Swedish Orphan Biovitrum AB
- Genentech, Inc
- Ferring Pharmaceuticals
- Glaxosmithkline, inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.